Kapitalizacja Rynkowa Zmiana Data
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Arrowhead Research USD 11.5B 2.72B 2026-06
Astellas Pharma JPY 3.94T 622.52B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
BioMarin Pharmaceutical USD 11.15B 91M 2026-11
Celltrion KRW 1.81T 620B 2026-06
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Exelixis USD 19.82B 5.34B 2026-11
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Kangmei Pharma CNY 16.59B 7.89B 2026-06
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Neurocrine Biosciences USD 14.54B 2.41B 2026-11
Novartis USD 292.09B 51.5B 2026-09
OPKO Health USD 3.38B 650M 2026-06
Organigram Holdings CAD 203.42M 49.05M 2026-06
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Pharma Mar EUR 1.17B 85.18M 2026-11
Qiagen NV USD 8.07B 197.36M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Sartorius EUR 17.42B 1.8B 2026-09
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 145.86B 19.78B 2026-11
Zealand Pharma A/S 20.84B 12.51B 2026-03
Zz Pientze Pharmaceu CNY 76.62B 5.43B 2026-11